{
     "PMID": "29369791",
     "OWN": "NLM",
     "STAT": "Publisher",
     "LR": "20180226",
     "IS": "1095-9327 (Electronic) 1044-7431 (Linking)",
     "VI": "88",
     "DP": "2018 Feb 2",
     "TI": "Aging exacerbates cognitive and anxiety alterations induced by an intracerebroventricular injection of amyloid-beta1-42 peptide in mice.",
     "PG": "93-106",
     "LID": "S1044-7431(17)30056-8 [pii] 10.1016/j.mcn.2018.01.005 [doi]",
     "AB": "An increasing body of evidence indicates that the activation of indoleamine-2,3-dyoxigenase (IDO), a first and rate-limiting enzyme in the kynurenine (KYN) pathway, is involved in Abeta1-42-neurotoxicity and AD pathogenesis. We have reported for the first time that brain IDO activation is related to Abeta1-42 exposure in young mice. Because aging is characterized by a brain dyshomeostasis and because it remains the most dominant risk factor for AD, the purpose of this study was to determine whether aging is associated with a higher sensitivity to behavioural and neurochemical alterations elicited by an intracerebroventricular (i.c.v.) injection of Abeta1-42 (400pmol/mice), and whether KYN pathway is involved in these effects. We confirmed that aged mice displayed higher cognitive deficit in the object recognition test and higher anxiety-like behaviour in the elevated plus-maze and open field tests after the Abeta1-42 administration. Aged mice also responded to Abeta1-42 with a higher deficiency of brain-derived neurotrophic factor, glutathione levels and total radical-trapping antioxidant capacity, a higher IDO activity, and a higher KYN and KYN/tryptophan ratio in the prefrontal cortex and hippocampus. These effects of Abeta1-42 were associated with a higher proinflammatory status, as measured by higher levels of interleukin-6, lower levels of interleukin-10 and higher expression of glial fibrillary acidic protein (GFAP) and allograft inflammatory factor 1 (Iba1) in the brain of aged mice. These results represent primary evidence suggesting that age-associated inflammatory signature and down-regulation of neuroprotectants in the brain render aged mice more vulnerable to Abeta1-42-induced memory loss, anxiety symptoms and KYN pathway dysregulation.",
     "CI": [
          "Copyright (c) 2018 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Souza, Leandro Cattelan",
          "Jesse, Cristiano R",
          "Del Fabbro, Lucian",
          "de Gomes, Marcelo Gomes",
          "Gomes, Nathalie Savedra",
          "Filho, Carlos Borges",
          "Goes, Andre Tiago Rossito",
          "Wilhelm, Ethel Antunes",
          "Luchese, Cristiane",
          "Roman, Silvane Souza",
          "Boeira, Silvana Peterini"
     ],
     "AU": [
          "Souza LC",
          "Jesse CR",
          "Del Fabbro L",
          "de Gomes MG",
          "Gomes NS",
          "Filho CB",
          "Goes ATR",
          "Wilhelm EA",
          "Luchese C",
          "Roman SS",
          "Boeira SP"
     ],
     "AD": "Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Electronic address: leandrosouza@unipampa.edu.br. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitario, s/n, 96160-000 Capao do Leao, RS, Brazil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitario, s/n, 96160-000 Capao do Leao, RS, Brazil. Universidade Regional Integrada, Campus Erechim, CEP 99700-000, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20180202",
     "PL": "United States",
     "TA": "Mol Cell Neurosci",
     "JT": "Molecular and cellular neurosciences",
     "JID": "9100095",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Aging",
          "Alzheimer's disease",
          "Anxiety",
          "Depression",
          "Indoleamine-2,3-dyoxigenase",
          "Kynurenine",
          "Memory",
          "Neuroinflammation"
     ],
     "EDAT": "2018/01/26 06:00",
     "MHDA": "2018/01/26 06:00",
     "CRDT": [
          "2018/01/26 06:00"
     ],
     "PHST": [
          "2017/02/16 00:00 [received]",
          "2018/01/11 00:00 [revised]",
          "2018/01/15 00:00 [accepted]",
          "2018/01/26 06:00 [pubmed]",
          "2018/01/26 06:00 [medline]",
          "2018/01/26 06:00 [entrez]"
     ],
     "AID": [
          "S1044-7431(17)30056-8 [pii]",
          "10.1016/j.mcn.2018.01.005 [doi]"
     ],
     "PST": "aheadofprint",
     "SO": "Mol Cell Neurosci. 2018 Feb 2;88:93-106. doi: 10.1016/j.mcn.2018.01.005.",
     "term": "hippocampus"
}